![Cancers | Free Full-Text | HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness | HTML Cancers | Free Full-Text | HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness | HTML](https://www.mdpi.com/cancers/cancers-13-04778/article_deploy/html/images/cancers-13-04778-g002.png)
Cancers | Free Full-Text | HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness | HTML
![Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO](https://www.esmo.org/var/esmo/storage/images/esmo/esmo-staff/impakt-prep/impakt-2015-news/abstract-39o-impakt-2015/1137949-1-eng-GB/Abstract-39O-IMPAKT-2015_i1200.jpg)
Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO
![Immunohistochemical profiles of ER, PR, HER2 and Ki-67 markers in the... | Download Scientific Diagram Immunohistochemical profiles of ER, PR, HER2 and Ki-67 markers in the... | Download Scientific Diagram](https://www.researchgate.net/profile/Rafael-Rocha-14/publication/235604812/figure/fig1/AS:393317297737740@1470785559964/Immunohistochemical-profiles-of-ER-PR-HER2-and-Ki-67-markers-in-the-tumor-sample-from.png)
Immunohistochemical profiles of ER, PR, HER2 and Ki-67 markers in the... | Download Scientific Diagram
![Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer - Journal of Thoracic Oncology Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2039558489/2053178611/gr1.jpg)
Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer - Journal of Thoracic Oncology
PLOS ONE: Serum HER2 Level Measured by Dot Blot: A Valid and Inexpensive Assay for Monitoring Breast Cancer Progression
![Various epigenetic markers involved in HER2 positive breast cancer.... | Download Scientific Diagram Various epigenetic markers involved in HER2 positive breast cancer.... | Download Scientific Diagram](https://www.researchgate.net/profile/Anjana-Munshi/publication/311648651/figure/fig1/AS:614286271459344@1523468668425/Various-epigenetic-markers-involved-in-HER2-positive-breast-cancer-Major-epigenetic.png)
Various epigenetic markers involved in HER2 positive breast cancer.... | Download Scientific Diagram
![Identification of gene markers for HER2+, Luminal A/B and TNBC. (A)... | Download Scientific Diagram Identification of gene markers for HER2+, Luminal A/B and TNBC. (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/327517799/figure/fig3/AS:668386157674514@1536367086840/Identification-of-gene-markers-for-HER2-Luminal-A-B-and-TNBC-A-Marker-heatmap.jpg)
Identification of gene markers for HER2+, Luminal A/B and TNBC. (A)... | Download Scientific Diagram
![Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-72661-9/MediaObjects/41598_2020_72661_Fig1_HTML.png)
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports
![Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials - The Lancet Oncology Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6e1e18fc-482d-48bf-b9bc-066b5ed1142d/gr1_lrg.jpg)
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials - The Lancet Oncology
![Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells | BMC Biology | Full Text Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells | BMC Biology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12915-014-0072-6/MediaObjects/12915_2014_Article_72_Fig2_HTML.jpg)
Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells | BMC Biology | Full Text
![Detection of cancer marker Her2 with QD-IgG.(A, C) Fixed breast cancer... | Download Scientific Diagram Detection of cancer marker Her2 with QD-IgG.(A, C) Fixed breast cancer... | Download Scientific Diagram](https://www.researchgate.net/profile/Marcel-Bruchez/publication/11010319/figure/fig3/AS:271640802099214@1441775622979/Detection-of-cancer-marker-Her2-with-QD-IgGA-C-Fixed-breast-cancer-SK-BR-3-cells-were.png)
Detection of cancer marker Her2 with QD-IgG.(A, C) Fixed breast cancer... | Download Scientific Diagram
![Mitochondrial MKP1 Is a Target for Therapy-Resistant HER2-Positive Breast Cancer Cells | Cancer Research Mitochondrial MKP1 Is a Target for Therapy-Resistant HER2-Positive Breast Cancer Cells | Cancer Research](https://cancerres.aacrjournals.org/content/canres/74/24/7498/F1.large.jpg)
Mitochondrial MKP1 Is a Target for Therapy-Resistant HER2-Positive Breast Cancer Cells | Cancer Research
![A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity - eBioMedicine A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4c4e7f5f-f38e-4370-af17-c57863e9ac0d/gr1.jpg)
A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity - eBioMedicine
![HER2 overexpression induced pSTAT3 and stem cell marker expression in... | Download Scientific Diagram HER2 overexpression induced pSTAT3 and stem cell marker expression in... | Download Scientific Diagram](https://www.researchgate.net/profile/Jay-Vadgama/publication/259114822/figure/fig1/AS:297050680905728@1447833809382/HER2-overexpression-induced-pSTAT3-and-stem-cell-marker-expression-in-ER-dependent.png)
HER2 overexpression induced pSTAT3 and stem cell marker expression in... | Download Scientific Diagram
![Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-72661-9/MediaObjects/41598_2020_72661_Fig3_HTML.png)
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports
![Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence - Shi - 2019 - Cancer Medicine - Wiley Online Library Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence - Shi - 2019 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b1a82b10-c3b3-4ff6-98fa-4f3a6ee4dd44/cam42006-fig-0002-m.jpg)
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence - Shi - 2019 - Cancer Medicine - Wiley Online Library
![Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - Annals of Oncology Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/96ca284f-7050-4a5a-a243-5a5f6180eb17/gr1.jpg)
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - Annals of Oncology
![Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors - Cancer Treatment Reviews Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors - Cancer Treatment Reviews](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/68c82d5e-187b-4155-9724-09a3da3a98bc/gr1_lrg.jpg)